Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014

3 Tampilan
administrator
administrator
07/30/23

Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.

Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com

  • Kategori

Menampilkan lebih banyak

0 Komentar Sortir dengan

Tidak ada komentar yang ditemukan

Komentar Facebook

Berikutnya